VS-6766+Abema+Fulv in Met HR+/HER- BC

Clinical trial NCT05608252 · RECRUITING

Trial details

NCT number: NCT05608252
Sponsor: Adrienne G. Waks
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Hormone Receptor-positive Breast Cancer Hormone Receptor Positive HER-2 Negative Breast Cancer

Start date: 2023-02-23
Primary completion: 2027-12-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.